Publicaciones en colaboración con investigadores/as de Medical University of Graz (4)

2024

  1. Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

    New England Journal of Medicine, Vol. 390, Núm. 15, pp. 1394-1407

  2. Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

    The Lancet, Vol. 403, Núm. 10437, pp. 1635-1648

2023

  1. Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction

    Journal of the American College of Cardiology, Vol. 82, Núm. 22, pp. 2087-2096

  2. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.

    New England Journal of Medicine, Vol. 389, Núm. 12, pp. 1069-1084